Ending America’s Gun Violence Epidemic
From personal stories of survival to gun policies already making a difference—the latest issue of Hopkins Bloomberg Public Health magazine brings a public health lens to ending gun violence in the U.S.
Headlines
Five Covid Lessons for Public Health
The pandemic exposed shortcomings in efforts to secure our collective health. Here’s how to get things back on track. By Dean Ellen J. MacKenzie
Violence, Interrupted: Community-Driven Strategies for Reducing Gun Violence
Arrests and incarceration won’t stop urban gun violence. Instead, a growing number of researchers say community violence prevention is the most promising solution.
Law Enforcement With a Public Health Lens
"We're not going to solve violence by arresting everyone."
Baltimore’s No-Prosecution Policy for Low-Level Drug Possession and Prostitution Finds Almost No Rearrests for Serious Offenses
The findings suggest the new no-prosecution policies did not result in increased public complaints about drug use or sex work in Baltimore, and that those who had charges dropped did not go on to commit serious crimes.
Molnupiravir: The Game-Changing Antiviral Pill for COVID-19?
A Q&A about the experimental drug that could soon be granted emergency use authorization for some people with mild to moderate COVID-19.
Two Bloomberg School Faculty Among 10 Johns Hopkins Researchers Elected to National Academy of Medicine
Johns Hopkins Bloomberg School of Public Health Professor Darrell Gaskin, PhD, MS, has been elected to the National Academy of Medicine, as has Tener Goodwin Veenema, PhD, MPH, MS. Eight Johns Hopkins colleagues from the School of Medicine were also elected to the NAM.
Bloomberg American Health Summit 2021
Join us November 10 from 9:30 a.m.-11 a.m. as speakers explore the most pressing topics in public health from the past year, including how to advance equity in underserved communities, lessons learned from the COVID-19 pandemic, and how best to prepare for the next public health crisis. Initiative fellows and faculty will highlight how their work is pushing U.S. public health forward.
Our Academic Program Offerings
Our programs welcome those from within and outside the traditional boundaries of public health. Whether you're a future college graduate, a midcareer public health leader, or someone looking to make a career change, we have a program for you.
How Collaborative Leadership Is Helping Us Through Tough Times
"The pandemic has been my greatest test as a leader, but I took comfort in knowing I wouldn’t be making decisions alone."
Meet Our Faculty
Our faculty are world-renowned experts, and trusted advisers to our students, public health leaders, and the public.
Narangerel Gombojav
Narangerel Gombojav, MD, PhD, ScM, seeks to improve maternal, child and adolescent health outcomes through data-driven and family engagement on-line tools.
Mark Kohr
Mark Kohr, PhD, researches how male and female hearts differ in response to injury and environmental factors.
Carol Underwood
Carol Underwood, PhD '93, MA, MA, studies the role of gender, social class, and marginalization in global health outcomes to contribute to the wellbeing of populations.
Weiqiang Zhou
Weiqiang Zhou, PhD, develops statistical and computational tools for integrative analysis of large-scale genomic data to study gene regulation in cancer and immune system.
Why Choose the Johns Hopkins Bloomberg School of Public Health?
#1
Ranked by U.S. News & World Report since 1994
1st
and Largest School of Public Health
1,800+
Courses Offered
80+
Research Centers and Institutes
26K+
Alumni Living in over 150 Countries
90+
Degree Programs
40
Certificate Programs
5:1
Student-to-Primary-Faculty Ratio
Voices on Vax
This initiative is bringing Baltimore’s youth voices to the conversation about the COVID vaccine with vaccine stories by and for Baltimore teens and their families, complete with a helpful step-by-step guide for creating videos.
Support Our Work
Our work is made possible in part by contributions from Bloomberg School donors.